Takanori Morikawa

6PUBLICATIONS
12CO-AUTHORS
Epidemiological methodsPredictive and prognostic markersMicro-manipulationCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 28, 2023
Current status and therapeutic strategy of acute acalculous cholecystitis: Japanese nationwide survey in the era of the Tokyo guidelines.

Takanori Morikawa, Masanori Akada, Kenji Shimizu

|Nov 21, 2022
Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection.

Tatsuo Hata, Masamichi Mizuma, Fuyuhiko Motoi

|Nov 07, 2022
Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer.

Tatsuo Hata, Kazuharu Chiba, Masamichi Mizuma

|Jan 26, 2022
Laparoscopic and robot-assisted surgery for adult congenital biliary dilatation achieves favorable short-term outcomes without increasing the risk of late complications.

Takanori Morikawa, Hideo Ohtsuka, Tatsuyuki Takadate

|Nov 10, 2021
Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population.

Tatsuo Hata, Masamichi Mizuma, Fuyuhiko Motoi

|May 22, 2021
Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non-metastatic disease.

Tatsuo Hata, Masamichi Mizuma, Masahiro Iseki

Pageof 1

Frequent Collaborators

4 joint publications

Tatsuo Hata

4 joint publications

Masamichi Mizuma

4 joint publications

Kei Nakagawa

4 joint publications

Fuyuhiko Motoi